No evidence of benefit from antibiotic lock therapy in pediatric oncology patients with central line-related bloodstream infection: Results of a retrospective matched cohort study and review of the literature

Pediatric Blood and Cancer

Volumn 61, Issue 10, 2014, Pages 1811-1815

  Wolf, Joshua ^a,b,c   Allison, Kim J ^a   Tang, Li ^a   Sun, Yilun ^a   Hayden, Randall T ^a   Flynn, Patricia M ^a,b  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^c UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Bacteremia; Catheter related infections; Catheterization, central venous; Child

Indexed keywords

CEFTAZIDIME; CEFTRIAXONE; GENTAMICIN; MEROPENEM; VANCOMYCIN;

ABSENCE OF SIDE EFFECTS; ADJUVANT THERAPY; ADOLESCENT; ADULT; ANTIBIOTIC LOCK THERAPY; ANTIBIOTIC THERAPY; ARTICLE; CANCER PATIENT; CATHETER INFECTION; CATHETER REMOVAL; CHILD; CHILDHOOD CANCER; CHRONOTHERAPY; CLINICAL ARTICLE; COHORT ANALYSIS; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; DRUG TREATMENT FAILURE; EVIDENCE BASED PRACTICE; FEMALE; HEALTH CARE QUALITY; HIGH RISK PATIENT; HUMAN; INFANT; MALE; MONOTHERAPY; NEWBORN; PEDIATRIC HOSPITAL; PRIORITY JOURNAL; RELAPSE; RETROSPECTIVE STUDY; RISK REDUCTION;

BACTEREMIA; CATHETER-RELATED INFECTIONS; CATHETERIZATION, CENTRAL VENOUS; CHILD;

ADOLESCENT; ANTI-BACTERIAL AGENTS; CATHETER-RELATED INFECTIONS; CATHETERIZATION, CENTRAL VENOUS; CENTRAL VENOUS CATHETERS; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; FEMALE; HUMANS; INFANT; MALE; PEDIATRICS; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84908556142     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.25101     Document Type: Article

References (30)

1. Mirro J Jr, Rao BN, Stokes DC, et al. A prospective study of Hickman/Broviac catheters and implantable ports in pediatric oncology patients. J Clin Oncol 1989; 7:214-222.
2. Choi SW, Chang L, Hanauer DA, et al. Rapid reduction of central line infections in hospitalized pediatric oncology patients through simple quality improvement methods. Pediatr Blood Cancer 2013; 60:262-269.
3. Newman N, Issa A, Greenberg D, et al. Central venous catheter-associated bloodstream infections. Pediatr Blood Cancer 2012; 59:410-414.
4. Wolf J, Curtis N, Worth LJ, et al. Central line-associated bloodstream infection in children: An update on treatment. Pediatr Infect Dis J 2013; 32:905-910.
5. Adler A, Yaniv I, Solter E, et al. Catheter-associated bloodstream infections in pediatric hematology-oncology patients: Factors associated with catheter removal and recurrence. J Pediatr Hematol Oncol 2006; 28:23-28.
6. Aledo A, Heller G, Ren L, et al. Septicemia and septic shock in pediatric patients: 140 consecutive cases on a pediatric hematology-oncology service. J Pediatr Hematol Oncol 1998; 20:215-221.
7. Flynn PM, Willis B, Gaur AH, et al. Catheter design influences recurrence of catheter-related bloodstream infection in children with cancer. J Clin Oncol 2003; 21:3520-3525.
8. Rinke ML, Milstone AM, Chen AR, et al. Ambulatory pediatric oncology CLABSIs: Epidemiology and risk factors. Pediatr Blood Cancer 2013; 60:1882-1889.
9. Stamou SC, Maltezou HC, Pourtsidis A, et al. Hickman-Broviac catheter-related infections in children with malignancies. Mt Sinai J Med 1999; 66:320-326.
10. Biwersi C, Hepping N, Bode U, et al. Bloodstream infections in a German paediatric oncology unit: Prolongation of inpatient treatment and additional costs. Int J Hyg Environ Health 2009; 212:541-546.
11. Zimlichman E, Henderson D, Tamir O, et al. Health care-associated infections: A meta-analysis of costs and financial impact on the US health care system. JAMA Intern Med 2013; 173:2039-2046.
12. Flynn PM, Shenep JL, Stokes DC, et al. In situ management of confirmed central venous catheter-related bacteremia. Pediatr Infect Dis J 1987; 6:729-734.
13. Raad I, Davis S, Khan A, et al. Impact of central venous catheter removal on the recurrence of catheter-related coagulase-negative staphylococcal bacteremia. Infect Control Hosp Epidemiol 1992; 13:215-221.
14. Mermel LA, Allon M, Bouza E, et al. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America. Clin Infect Dis 2009; 49:1-45.
15. Polgreen PM, Beekmann SE, Diekema DJ, et al. Wide variability in the use of antimicrobial lock therapy and prophylaxis among infectious diseases consultants. Infect Control Hosp Epidemiol 2010; 31:554-557.
16. Schoot RA, van Dalen EC, van Ommen CH, et al. Antibiotic and other lock treatments for tunnelled central venous catheter-related infections in children with cancer. Cochrane Database Syst Rev 2013; 6:CD008975.
17. Gaur AH, Flynn PM, Giannini MA, et al. Difference in time to detection: A simple method to differentiate catheter-related from non-catheter-related bloodstream infection in immunocompromised pediatric patients. Clin Infect Dis 2003; 37:469-475.
18. Gaur AH, Flynn PM, Heine DJ, et al. Diagnosis of catheter-related bloodstream infections among pediatric oncology patients lacking a peripheral culture, using differential time to detection. Pediatr Infect Dis J 2005; 24:445-449.
19. Lu L, Liu C. Analysis of correlated recurrent and terminal events data in SAS. In: Proceedings of the Northeast SAS Users Group Conference. http://www.lexjansen.com/nesug/nesug08/sa/sa16.pdf, accessed May 14, 2014.
20. Liu L, Wolfe RA, Huang X. Shared frailty models for recurrent events and a terminal event. Biometrics 2004; 60:747-756.
21. Fine JP, Gray RJ. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 1999; 94:496-509.
22. Schemper M, Wakounig S, Heinze G. The estimation of average hazard ratios by weighted Cox regression. Stat Med 2009; 28:2473-2489.
23. Rijnders BJ, Van Wijngaerden E, Vandecasteele SJ, et al. Treatment of long-term intravascular catheter-related bacteraemia with antibiotic lock: Randomized, placebo-controlled trial. J Antimicrob Chemother 2005; 55:90-94.
24. O'Horo JC, Silva GL, Safdar N. Anti-infective locks for treatment of central line-associated bloodstream infection: A systematic review and meta-analysis. Am J Nephrol 2011; 34:415-422.
25. Beigi AA, Khansoltani S, Masoudpour H, et al. Influence of intralumenal and antibiotic-lock of vancomycin on the rate of catheter removal in the patients with permanent hemodialysis catheters. Saudi J Kidney Dis Transpl 2010; 21:54-58.
26. Lee H, Young K, Song Y, et al. Treatment of catheter-related bacteremia with an antibiotic lock protocol in hemodialysis patients. Korean J Nephrol 2005; 24:903-911.
27. Onder AM, Chandar J, Billings AA, et al. Comparison of early versus late use of antibiotic locks in the treatment of catheter-related bacteremia. Clin J Am Soc Nephrol 2008; 3:1048-1056.
28. Poole CV, Carlton D, Bimbo L, et al. Treatment of catheter-related bacteraemia with an antibiotic lock protocol: Effect of bacterial pathogen. Nephrol Dial Transplant 2004; 19:1237-1244.
29. Fortun J, Grill F, Martin-Davila P, et al. Treatment of long-term intravascular catheter-related bacteraemia with antibiotic-lock therapy. J Antimicrob Chemother 2006; 58:816-821.
30. Easterbrook PJ, Berlin JA, Gopalan R, et al. Publication bias in clinical research. Lancet 1991; 337:867-872.